Then again, it was always the industry â€™s expectation that the law would prove flawed in places, and that those shortcomings would be addressed legislatively. As Karen Ignagni, the lead lobbyist for the   industry during the formation and passage of Obamacare and now president and C. E. O. of EmblemHealth, tactfully puts it: "On the Affordable Care Act, there was a strong difference of opinion between Democrats and Republicans going back to the initial days of discussion. And so there was never a  . 